Yüklüyor......
Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
The advent of immune-checkpoint inhibitors (ICIs) targeting the programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) axis, produced a paradigm change of the treatment algorithm for metastatic, non-oncogene addicted, non-small cell lung cancer (NSCLC). However, the majority of patients with on...
Kaydedildi:
| Yayımlandı: | Transl Lung Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815346/ https://ncbi.nlm.nih.gov/pubmed/33489826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-710 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|